Effect of pH on radiometric MICs of clarithromycin against 18 species of mycobacteria
Open Access
- 1 December 1992
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 36 (12) , 2841-2842
- https://doi.org/10.1128/aac.36.12.2841
Abstract
The antimycobacterial spectrum of clarithromycin, a new macrolide drug, was screened against 26 strains belonging to 18 species of mycobacteria by determining radiometric MICs by Bactec methodology at three different pHs, i.e., pH 6.0, 6.8, and 7.4. The MICs obtained at pH 7.4 were 1 to 2 or more dilutions lower in some of the species than those obtained at pH 6.8, whereas they were significantly higher at pH 6.0. The numbers of species for which MICs were below the Cmax levels of clarithromycin (i.e., 4 micrograms/ml) at different pHs were 8 of 18 species at pH 6.0, 13 of 18 species at pH 6.8, and 14 of 18 species at pH 7.4. The drug possessed promising activity against such potential pathogens as M. avium, M. scrofulaceum, M. szulgai, M. malmoense, M. xenopi, M. marinum, and M. kansasii and rare pathogens like M. chelonei.Keywords
This publication has 6 references indexed in Scilit:
- Clarithromycin Minimal Inhibitory and Bactericidal Concentrations againstMycobacterium aviumAmerican Review of Respiratory Disease, 1992
- In vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against Mycobacterium tuberculosis compared with activities of ofloxacin and ciprofloxacinAntimicrobial Agents and Chemotherapy, 1991
- Intracellular distribution and activity of antibioticsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- New directions for macrolide antibiotics: pharmacokinetics and clinical efficacyAntimicrobial Agents and Chemotherapy, 1989
- New directions for macrolide antibiotics: structural modifications and in vitro activityAntimicrobial Agents and Chemotherapy, 1989
- Uptake, accumulation, and egress of erythromycin by tissue culture cells of human originAntimicrobial Agents and Chemotherapy, 1985